News

Exponent’s (NASDAQ:EXPO) Q2: Beats On Revenue But Quarterly Revenue Guidance Slightly Misses Expectations
Scientific consulting firm Exponent (NASDAQ:EXPO) reported Q2 CY2025 results exceeding the market’s revenue expectations, ...